| Title |
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal CancerPlasma-only ctDNA-guided MRD Detection in Patients with CRC
|
|---|---|
| Published in |
Clinical Cancer Research, April 2021
|
| DOI | 10.1158/1078-0432.ccr-21-0410 |
| Pubmed ID | |
| Authors |
Aparna R. Parikh, Emily E. Van Seventer, Giulia Siravegna, Anna V. Hartwig, Ariel Jaimovich, Yupeng He, Katie Kanter, Madeleine G. Fish, Kathryn D. Fosbenner, Benchun Miao, Susannah Phillips, John H. Carmichael, Nihaarika Sharma, Joy Jarnagin, Islam Baiev, Yojan S. Shah, Isobel J. Fetter, Heather A. Shahzade, Jill N. Allen, Lawrence S. Blaszkowsky, Jeffrey W. Clark, Jon S. Dubois, Joseph W. Franses, Bruce J. Giantonio, Lipika Goyal, Samuel J. Klempner, Ryan D. Nipp, Eric J. Roeland, David P. Ryan, Colin D. Weekes, Jennifer Y. Wo, Theodore S. Hong, Liliana Bordeianou, Cristina R. Ferrone, Motaz Qadan, Hiroko Kunitake, David Berger, Rocco Ricciardi, James C. Cusack, Victoria M. Raymond, AmirAli Talasaz, Genevieve M. Boland, Ryan B. Corcoran |
X Demographics
The data shown below were collected from the profiles of 71 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 25 | 35% |
| Italy | 6 | 8% |
| Spain | 3 | 4% |
| Australia | 3 | 4% |
| United Kingdom | 2 | 3% |
| Brazil | 2 | 3% |
| India | 2 | 3% |
| Canada | 2 | 3% |
| Greece | 1 | 1% |
| Other | 0 | 0% |
| Unknown | 25 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 32 | 45% |
| Scientists | 20 | 28% |
| Practitioners (doctors, other healthcare professionals) | 15 | 21% |
| Science communicators (journalists, bloggers, editors) | 4 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 164 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 164 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 26 | 16% |
| Student > Ph. D. Student | 15 | 9% |
| Other | 10 | 6% |
| Student > Postgraduate | 8 | 5% |
| Student > Master | 8 | 5% |
| Other | 19 | 12% |
| Unknown | 78 | 48% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 31 | 19% |
| Biochemistry, Genetics and Molecular Biology | 26 | 16% |
| Agricultural and Biological Sciences | 10 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 2% |
| Unspecified | 3 | 2% |
| Other | 7 | 4% |
| Unknown | 83 | 51% |
Attention Score in Context
This research output has an Altmetric Attention Score of 270. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 April 2023.
All research outputs
#135,704
of 25,743,152 outputs
Outputs from Clinical Cancer Research
#57
of 13,302 outputs
Outputs of similar age
#4,118
of 456,248 outputs
Outputs of similar age from Clinical Cancer Research
#1
of 181 outputs
Altmetric has tracked 25,743,152 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,302 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,248 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 181 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.